Lew Jennifer — SEC Form 4 filings
SEC reporting owner CIK 1465994. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-15.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-23 to 2026-06-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 29,794 shares, $133,741 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 7,851 shares @ $5.11 ($40,119) in Annexon, Inc., filed 2026-02-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Annexon, Inc. (ANNX) | EVP & CHIEF FINANCIAL OFFICER | 11 | — | 9 legs · 29,794 sh · $133,741 | 6 |
| Boundless Bio, Inc. (BOLD) | Director | 3 | — | — | 3 |
Form 4 filings — Lew Jennifer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | Boundless Bio, Inc. (BOLD) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Annexon, Inc. (ANNX) | Sale (S): 5,565 @ $5.42 | EDGAR |
| 2026-02-23 | 4 | Annexon, Inc. (ANNX) | Grant/award (A): 62,500 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Annexon, Inc. (ANNX) | Sale (S): 7,851 @ $5.11 | EDGAR |
| 2025-07-16 | 4 | Annexon, Inc. (ANNX) | Sale (S): 1,117 @ $2.58 | EDGAR |
| 2025-06-23 | 4 | Boundless Bio, Inc. (BOLD) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Annexon, Inc. (ANNX) | Grant/award (A): 44,963 @ $0 · Grant/award (A): 272,575 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Annexon, Inc. (ANNX) | Sale (S): 6,912 @ $2.92 | EDGAR |
| 2025-02-18 | 4 | Annexon, Inc. (ANNX) | Sale (S): 1,786 @ $2.98 | EDGAR |
| 2024-07-17 | 4 | Annexon, Inc. (ANNX) | Sale (S): 1,104 @ $6.03 | EDGAR |
| 2024-03-29 | 4 | Boundless Bio, Inc. (BOLD) | Grant/award (A): 13,219 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | Annexon, Inc. (ANNX) | Grant/award (A): 39,000 @ $0 · Sale (S): 2,593 @ $5.53 · Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | Annexon, Inc. (ANNX) | Sale (S): 1,809 @ $5.54 | EDGAR |
| 2024-01-23 | 4 | Annexon, Inc. (ANNX) | Sale (S): 1,057 @ $3.84 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1465994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →